CDK7-IN-14
Product Specifications
UNSPSC Description
CDK7-IN-14 is a potent inhibitor of CDK7. CDK7-IN-14 is a pyrimidinyl derivative compound. CDK7-IN-14 has the potential for the research of various cancers, especially the cancer with transcriptional dysregulation (extracted from patent CN114249712A, compound 3)[1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk7-in-14.html
Solubility
10 mM in DMSO
Smiles
CP(C)(C1=C(C=CC2=C1NC=C2C3=NC(N[C@H]4CCC[C@@H](C4)N)=NC=C3C(F)(F)F)C#N)=O
Molecular Weight
476.43
References & Citations
[1]Guanpeng Qiu, et al. Pyrimidinyl derivatives, method for the production thereof and use thereof. Patent CN114249712A.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-147598/CDK7-IN-14-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-147598/
Clinical Information
No Development Reported
CAS Number
2765676-49-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7149259 Inquire
Rabbit anti-Escherichia coli (strain K12) YBGO Polyclonal Antibody
Ask
View Details